Literature DB >> 1615946

Long-term hepatic memory for hypersensitivity to nitrofurantoin.

L A Paiva1, P J Wright, R S Koff.   

Abstract

Nitrofurantoin-induced hepatic injury has been established unequivocally as an entity by rechallenge experiences. We reviewed 12 previously reported cases in which rechallenge was described. The longest reported interval between initial injury and rechallenge-provoked injury was 4 yr. We report a 56-yr-old woman who experienced severe hepatocellular injury with brief low-dose administration of nitrofurantoin 17 yr after an initial hepatitis-like illness associated with ingestion of the drug. Despite a temporal relationship to nitrofurantoin administration and histologic features compatible with drug-induced hepatitis, the initial bout of hepatitis had been termed "infectious." Our case appears remarkable for the long interval between initial injury and rechallenge-induced injury. The severity of the hepatic injury seen on rechallenge underscores the concept that the inadvertent rechallenge can be dangerous. Failure to identify the first bout of hepatitis as nitrofurantoin-related, and failure to inform the patient about the possible relationship to nitrofurantoin, raises important risk-management concerns, because hepatic memory of nitrofurantoin hypersensitivity appears to be of long duration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1615946

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

1.  Nitrofurantoin-associated lung and liver toxicity leading to liver transplantation in a middle-aged patient.

Authors:  Tony K L Kiang; Jo-Ann Ford; Eric M Yoshida; Nilufar Partovi
Journal:  Can J Hosp Pharm       Date:  2011-07

2.  Nitrofurantoin rechallenge and recurrent toxicity.

Authors:  M C Bialas; H G Shetty; J Houghton; F Woods; P A Routledge
Journal:  Postgrad Med J       Date:  1997-08       Impact factor: 2.401

3.  Nitrofurantoin immune-mediated drug-induced liver injury: a serious complication of a commonly prescribed medication.

Authors:  Theresa Hydes; Mark Wright; Eleanor Jaynes; Kathryn Nash
Journal:  BMJ Case Rep       Date:  2014-03-05

4.  An Unusual Case of Drug-Induced Liver Injury Secondary to Nitrofurantoin Use.

Authors:  Stephen Wonnacott; Dhir Gala; Mili Shah; Diksha Kaul; Vikash Kumar
Journal:  Cureus       Date:  2022-07-15

5.  Role of cytochrome P450 reductase in nitrofurantoin-induced redox cycling and cytotoxicity.

Authors:  Yun Wang; Joshua P Gray; Vladimir Mishin; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Free Radic Biol Med       Date:  2007-12-23       Impact factor: 7.376

6.  Autoimmune hepatitis triggered by nitrofurantoin: a case series.

Authors:  Sally Appleyard; Ruma Saraswati; David A Gorard
Journal:  J Med Case Rep       Date:  2010-09-23

Review 7.  Drug-induced autoimmune-like hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-02-16       Impact factor: 3.487

8.  Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease.

Authors:  Jagannath M Sherigar; Richard Fazio; Minsheng Zuang; Edward Arsura
Journal:  Clin Pract       Date:  2012-10-17

9.  Acute respiratory distress syndrome and hepatotoxicity associated with single dose nitrofurantoin use.

Authors:  Gokhan Sargın; Osman Elbek; Cem Balantekin; Ibrahim Meteoglu; Nil Culhacı
Journal:  Case Rep Pulmonol       Date:  2012-11-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.